Prevalence of Epstein-Barr virus (EBV) in Iranian breast carcinoma patients

28Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Breast cancer (BC) is the most common malignancy affecting females worldwide. Various risk factorsplay a role in the developing of BC. Infectious agents like viruses have been proposed for this cancer and Epstein-Barr virus (EBV) is a widely researched candidate virus. This study detects the presence of EBV-DNA in breast cancer patients. Methods: The study was conducted on 59 formalin-fied paraffi-embedded (FFPE) tissue blocks samples of women with breast carcinoma and 11 non-neoplastic breast controls. The DNA was extracted for all the samples. Then detection of EBNA1 EBV was done by polymerase chain reaction (PCR). Results: EBV was detected in 6.7% (4/59) of patients while all breast control samples were negative. All patients with positive EBV-DNA were high tumor grades (II, and III). Also, they had a low level of educations. Conclusions: According to our fidings, it can be suggested that EBV may have a potential role in breast cancer development. However, this study provides substantial but not conclusive evidence for the involvement of viruses in BC disease development. Therefore, future investigations are needed to elucidate the exact role of EBV in breast cancer.

Author supplied keywords

Cite

CITATION STYLE

APA

Mofrad, M. G., Kazeminezhad, B., & Faghihloo, E. (2020). Prevalence of Epstein-Barr virus (EBV) in Iranian breast carcinoma patients. Asian Pacific Journal of Cancer Prevention, 21(1), 133–137. https://doi.org/10.31557/APJCP.2020.21.1.133

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free